HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SR 144528

a CB2 cannabinoid receptor antagonist; structure in first source
Also Known As:
N-(1,3,3-trimethylbicyclo(2.2.1)heptan-2-yl)-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)pyrazole-3-carboxamide; SR-144528; SR144528
Networked: 42 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kinsey, Steven G: 2 articles (04/2015 - 10/2011)
2. Krylatov, A V: 2 articles (07/2008 - 10/2006)
3. Maslov, L N: 2 articles (07/2008 - 10/2006)
4. Crawford, D: 2 articles (07/2008 - 10/2006)
5. Lasukova, O V: 2 articles (07/2008 - 10/2006)
6. Rice, A S C: 2 articles (08/2007 - 05/2007)
7. Hohmann, A G: 2 articles (01/2007 - 01/2003)
8. Kishimoto, Seishi: 2 articles (12/2006 - 12/2004)
9. Sugiura, Takayuki: 2 articles (12/2006 - 12/2004)
10. Oka, Saori: 2 articles (12/2006 - 12/2004)

Related Diseases

1. Hyperalgesia
2. Hypersensitivity (Allergy)
3. Asthma (Bronchial Asthma)
4. Inflammation
5. Pain (Aches)

Related Drugs and Biologics

1. rimonabant
2. pyrazole
3. Carrageenan
4. cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)
5. CB2 Cannabinoid Receptor
6. CB1 Cannabinoid Receptor (CB1 Receptor)
7. 3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanol
8. AM 251 (AM251)
9. Antigens
10. anandamide (arachidonylethanolamide)

Related Therapies and Procedures

1. Self Administration (Administration, Self)
2. Ligation
3. Intraperitoneal Injections